Cullinan Therapeutics, Inc.
CGEM
$12.94
-$0.20-1.49%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 377.90M | 332.60M | 265.48M | 303.83M | 398.98M |
| Total Receivables | 2.83M | -- | -- | -- | 3.00M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.03M | 9.64M | 10.43M | 13.95M | 12.69M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 386.76M | 342.24M | 275.91M | 317.77M | 414.67M |
|
|
|||||
| Total Current Assets | 386.76M | 342.24M | 275.91M | 317.77M | 414.67M |
| Net Property, Plant & Equipment | 3.05M | 1.54M | 1.75M | 2.16M | 2.35M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 297.00K | 361.00K | 367.00K | 366.00K | 366.00K |
| Total Assets | 448.37M | 484.13M | 520.33M | 579.68M | 621.82M |
|
|
|||||
| Total Accounts Payable | 841.00K | 1.72M | 2.46M | 3.40M | 1.68M |
| Total Accrued Expenses | 35.12M | 28.33M | 21.97M | 19.81M | 26.23M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 780.00K | 1.19M | 1.39M | 1.35M | 1.30M |
| Total Finance Division Other Current Liabilities | 996.00K | 1.52M | 2.23M | 2.80M | 1.44M |
| Total Other Current Liabilities | 996.00K | 1.52M | 2.23M | 2.80M | 1.44M |
| Total Current Liabilities | 37.74M | 32.76M | 28.06M | 27.35M | 30.65M |
|
|
|||||
| Total Current Liabilities | 37.74M | 32.76M | 28.06M | 27.35M | 30.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.90M | -- | 125.00K | 493.00K | 849.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 39.64M | 32.76M | 28.18M | 27.84M | 31.50M |
|
|
|||||
| Common Stock & APIC | 995.83M | 987.80M | 978.34M | 968.08M | 958.70M |
| Retained Earnings | -588.12M | -537.41M | -486.80M | -416.74M | -368.24M |
| Treasury Stock & Other | 1.02M | 973.00K | 607.00K | 505.00K | -133.00K |
| Total Common Equity | 408.73M | 451.37M | 492.15M | 551.84M | 590.33M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 408.73M | 451.37M | 492.15M | 551.84M | 590.33M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 408.73M | 451.37M | 492.15M | 551.84M | 590.33M |
|
|
|||||